Member of the Henan Provincial Political Consultative Conference, Vice Chairman of the Henan General Chamber of Commerce, Vice Chairman of the Xinxiang Federation of Industry and Commerce, founded Wang Group in 2001 as the main founder, and has developed into a modern private enterprise group covering building materials, real estate, and biomedicine.

 Ph.D. from Brown University and postdoctoral fellow at Georgetown University, former Senior Chief Scientist at Roche, with experience in launching one new drug and pushing six new drugs to different clinical stages.

He is a talent under the "Hundred Talents Plan" of Henan Province and a specially appointed professor at Henan Normal University, engaged in the research and development of anti-tumor drugs for nearly 30 years.

PhD from Ocean University of China, professor at the School of Chemistry and Chemical Engineering, Henan Normal University, head of the Institute of Chemical Pharmaceutical Research, and director of the Henan Engineering Center.

Formerly served as an external expert for national new drug evaluation, and has long been engaged in new drug research and development, as well as drug variety transformation

PhD from Boston University, postdoctoral fellow at Harvard University, senior researcher, talent under the "Hundred Talents Program" in Hunan Province, specially appointed expert by the State Administration of Foreign Experts Affairs, and specially appointed professor at Hunan University. Engaged in biomedical research and management for nearly 30 years, leading and participating in the Sino US IND dual reporting of more than 10 new drugs.

Led the team to successfully promote more than 10 innovative drugs to phase I-III clinical trials.

Graduated from Beihang University, MBA from Zhengzhou University, with many years of experience in state-owned assets, civil technology, and management positions, responsible for company administration, personnel, finance, and other work。